(Q34559012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

5

Christine S Falk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Bernhard Frankenberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sybille Regn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Christiane Geiger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Elfriede Noessner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Heike Pohla

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Miran Javorovic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Tobias Silberzahn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Susanne Wilde

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Michael Siebels

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Ralph Oberneder

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Gerald Willimsky

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Antonio Pezzutto

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Thomas Blankenstein

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Dolores J Schendel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

5 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

166-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15997395%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00345-005-0505-5

13 January 2020

exact match

0 references

cites work

LFA-1 contributes an early signal for NK cell cytotoxicity.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-005-0505-5

Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells

21 January 2018

1 reference

12 December 2020

A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Human renal-cell carcinoma tissue contains dendritic cells

1 reference

12 December 2020

Immunoregulatory T cells in tumor immunity

1 reference

12 December 2020

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

1 reference

12 December 2020

Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes

1 reference

12 December 2020

Aging, immunity and cancer

1 reference

12 December 2020

Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.

1 reference

12 December 2020

Type I interferons promote cross-priming: more functions for old cytokines

1 reference

12 December 2020

Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes

1 reference

12 December 2020

Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.

1 reference

12 December 2020

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

1 reference

12 December 2020

Viral vectors for dendritic cell-based immunotherapy

1 reference

12 December 2020

Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors

1 reference

12 December 2020

Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity

1 reference

12 December 2020

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

12 December 2020

Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

1 reference

12 December 2020

Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.

1 reference

12 December 2020

Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.

1 reference

12 December 2020

Unique tumor antigens redefined as mutant tumor-specific antigens

1 reference

12 December 2020

Minimal recruitment and activation of dendritic cells within renal cell carcinoma

1 reference

12 December 2020

Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.

1 reference

12 December 2020

Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.

1 reference

12 December 2020

Genetic, cellular and immune approaches to disease therapy: past and future

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent

1 reference

12 December 2020

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

1 reference

12 December 2020

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

12 December 2020

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

1 reference

12 December 2020

The use of dendritic cells in cancer immunotherapy

1 reference

12 December 2020

Unravelling natural killer cell function: triggering and inhibitory human NK receptors

1 reference

12 December 2020

Roles of the NKG2D immunoreceptor and its ligands

1 reference

12 December 2020

Dendritic cells: a journey from laboratory to clinic

1 reference

12 December 2020

In vivo description of dendritic cells in human renal cell carcinoma

1 reference

12 December 2020

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

1 reference

12 December 2020

Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

12 December 2020

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1 reference

12 December 2020

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

1 reference

12 December 2020

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

12 December 2020

Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition

1 reference

12 December 2020

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

12 December 2020

Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.

1 reference

12 December 2020

Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

1 reference

12 December 2020

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

12 December 2020

Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma

1 reference

12 December 2020

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

12 December 2020

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

1 reference

12 December 2020

Alloreactive killer cells: hindrance and help for haematopoietic transplants

1 reference

12 December 2020

Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy

1 reference

12 December 2020

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

12 December 2020

Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells

1 reference

12 December 2020

Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines

1 reference

12 December 2020

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.

1 reference

12 December 2020

The B7-CD28 superfamily

1 reference

12 December 2020

RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis

1 reference

12 December 2020

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

12 December 2020

A stimulating presentation

1 reference

12 December 2020

Active immunization against cancer with dendritic cells: the near future

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

1 reference

12 December 2020

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes

1 reference

12 December 2020

Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

1 reference

12 December 2020